Collins Stewart initiates coverage on Rigel Pharmaceuticals (Nasdaq: RIGL) with a Hold.

Collins analyst says, "While Rigel has a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE